Expression of nuclear receptors of gingiva in polycystic ovarian syndrome: a preliminary case study

被引:9
作者
Asnani, K. P. [1 ]
Hingorani, D. [1 ]
Kheur, S. [2 ]
Deshmukh, V. L. [1 ]
Romanos, G. E. [3 ]
机构
[1] Dr DY Patil Vidyapeeth Dent Coll & Hosp, Dept Periodont, Pune 411018, Maharashtra, India
[2] Dr DY Patil Vidyapeeth Dent Coll & Hosp, Dept Oral Pathol, Pune 411018, Maharashtra, India
[3] SUNY Stony Brook, Sch Dent Med, Stony Brook, NY 11794 USA
关键词
Oestrogen; gingivitis; periodontitis; polycystic ovarian syndrome; ADVANCED GLYCATION ENDPRODUCTS; GRADE CHRONIC INFLAMMATION; SEX STEROID-HORMONES; OXIDATIVE STRESS; PERIODONTAL-DISEASE; RISK-FACTORS; WOMEN; ESTROGEN;
D O I
10.1111/adj.12176
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Oestrogen is mainly responsible for alterations in blood vessels and progesterone stimulates the production of inflammatory mediators. In females, during puberty, ovulation and pregnancy, there is an increase in the production of sex steroid hormones, which results in increased gingival inflammation, characterized by gingival enlargement, increased bleeding and crevicular fluid flow. This article presents a case of a patient who presented with a complaint of gingival swelling and spontaneous bleeding that persisted for more than two months. Her health history documented the recently diagnosed presence of polycystic ovarian syndrome. Clinical examination revealed enlarged painful gingival tissues, which bled when touched. After completion of Phase I therapy, the enlargement did not subside and a biopsy sample was taken. This was compared with another patient who had the same health condition but did not show any gingival enlargement. Testing of tissue samples for oestrogen and progesterone receptors showed the first patient to be positive for oestrogen receptors but negative for progesterone, whereas the control was negative for both. Positive oestrogen receptors suggest that polycystic ovarian syndrome has some effect on the periodontium. The dental consequences of this condition, highly prevalent among young females, are typically ignored. Further studies warrant establishment of a clinical association and future diagnosis.
引用
收藏
页码:252 / 257
页数:6
相关论文
共 30 条
[1]  
Agha-Hosseini F, 2006, IRAN J PUBLIC HEALTH, V35, P38
[2]  
Amar S, 1994, Periodontol 2000, V6, P79, DOI 10.1111/j.1600-0757.1994.tb00028.x
[3]  
Armitage G C, 1999, Ann Periodontol, V4, P1, DOI 10.1902/annals.1999.4.1.1
[4]   RISK-FACTORS FOR CORONARY-ARTERY DISEASE IN LEAN AND OBESE WOMEN WITH THE POLYCYSTIC-OVARY-SYNDROME [J].
CONWAY, GS ;
AGRAWAL, R ;
BETTERIDGE, DJ ;
JACOBS, HS .
CLINICAL ENDOCRINOLOGY, 1992, 37 (02) :119-125
[5]   Oxidative Stress, Systemic Inflammation, and Severe Periodontitis [J].
D'Aiuto, F. ;
Nibali, L. ;
Parkar, M. ;
Patel, K. ;
Suvan, J. ;
Donos, N. .
JOURNAL OF DENTAL RESEARCH, 2010, 89 (11) :1241-1246
[6]   POLYCYSTIC-OVARY-SYNDROME AND RISK FOR MYOCARDIAL-INFARCTION - EVALUATED FROM A RISK FACTOR MODEL BASED ON A PROSPECTIVE POPULATION STUDY OF WOMEN [J].
DAHLGREN, E ;
JANSON, PO ;
JOHANSSON, S ;
LAPIDUS, L ;
ODEN, A .
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 1992, 71 (08) :599-604
[7]   Increased serum advanced glycation end-products is a distinct finding in lean women with polycystic ovary syndrome (PCOS) [J].
Diamanti-Kandarakis, Evanthia ;
Katsikis, Ilias ;
Piperi, Christina ;
Kandaraki, Eleni ;
Piouka, Athanasia ;
Papavassiliou, Athanasios G. ;
Panidis, Dimitrios .
CLINICAL ENDOCRINOLOGY, 2008, 69 (04) :634-641
[8]   Periodontal disease in polycystic ovary syndrome [J].
Dursun, Erhan ;
Akalin, Ferda Alev ;
Guncu, Guliz Nigar ;
Cinar, Nese ;
Aksoy, Duygu Yazgan ;
Tozum, Tolga Fikret ;
Kilinc, Kamer ;
Yildiz, Bulent Okan .
FERTILITY AND STERILITY, 2011, 95 (01) :320-323
[9]   MEDICAL PROGRESS - POLYCYSTIC-OVARY-SYNDROME [J].
FRANKS, S .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (13) :853-861
[10]   Reactive oxygen species-induced oxidative stress in the development of insulin resistance and hyperandrogenism in polycystic ovary syndrome [J].
González, F ;
Rote, NS ;
Minium, J ;
Kirwan, JP .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (01) :336-340